NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

Market Cap	9.69M
Revenue (ttm)	2.21M
Net Income (ttm)	1.19M
Shares Out	144.60M
EPS (ttm)	0.01
PE Ratio	8.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	298
Average Volume	197,388
Open	0.0660
Previous Close	0.0660
Day's Range	0.0660 - 0.0660
52-Week Range	0.0330 - 0.0690
Beta	1.27
RSI	69.29
Earnings Date	May 27, 2025

About ASX:NSB

NeuroScientific Biopharmaceuticals Limited engages in the research and development of novel peptide-based pharmaceutical products. The company is involved in the development of therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative Alzheimer’s disease, multiple scierosis, glaucoma, optic nerve atrophy, and other diseases. The company was incorporated in 2002 and is based in Perth, Australia.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NSB